You or someone you love has been diagnosed with lung cancer. Perhaps you've already been told what the treatment plan is. Perhaps it's surgery, chemotherapy, radiotherapy — or some combination. Perhaps you've been told that surgery is not possible. Perhaps you've been told there are no further options.
And somewhere, beneath the shock and the fear, a quiet voice is asking: Is this definitely right? Is there anything else? Should I be seeing someone else?
That voice is worth listening to. Research consistently shows that second opinions in cancer care lead to changes in diagnosis, staging, or treatment recommendations in a significant proportion of cases. A second opinion is not an act of doubt — it is an act of care.
"I actively encourage patients to seek a second opinion before any major lung cancer treatment decision. Not because their first doctor is wrong — but because the stakes are too high to rely on a single perspective. If I am not the right surgeon for you, I will tell you so, and I will help you find who is."
This page explains what a lung cancer second opinion with Mr Marco Scarci involves, who benefits most, and how to arrange one — quickly, privately, and without disrupting your existing care.
These are the conversations that bring patients to Mr Scarci's clinic. If any of them sound familiar, you are in the right place.
This isn't a formality. Studies show that expert second opinions in cancer consistently alter diagnosis, staging, or treatment recommendations — sometimes dramatically.
Of cancer second opinions result in a significant change to diagnosis or treatment plan, according to published studies in thoracic oncology
Keyhole surgery eligibility is frequently reassessed at second opinion — patients told surgery was impossible are sometimes found to be suitable for minimally invasive approaches
Every second opinion is backed by a full multidisciplinary team review — oncologists, radiologists, pathologists, and thoracic surgeons together, not a single clinician's view
Imaging, scans, and records can be retrieved and reviewed within 24–48 hours — so the process does not delay your care
"My husband was told he was not suitable for surgery. We came to Mr Scarci for a second opinion. He reviewed everything, presented the case at an MDT, and told us that keyhole surgery was actually possible. That was three years ago. My husband has been clear ever since."
The question of whether a patient is suitable for lung cancer surgery is one of the most consequential — and most nuanced — decisions in thoracic oncology. It depends on tumour location, lung function, overall fitness, and surgical technique. Patients told "no" by a general surgeon are sometimes appropriate candidates when reviewed by a dedicated thoracic surgeon with experience in advanced minimally invasive approaches.
Not a rushed second consultation. A structured, thorough review of your entire case — backed by a full cancer multidisciplinary team.
No clock is watching. Mr Scarci takes the time to understand your complete history, your concerns, and what you've already been told. Family members are welcome. All your questions are answered in plain, honest language.
There is no need to collect or carry your own records. CT scans, PET scans, MRI, biopsy reports, and pathology results are retrieved electronically directly from your hospital — from the NHS or private sector. Records can typically be obtained within 24–48 hours.
Your case is formally presented at a cancer multidisciplinary team meeting comprising thoracic surgeons, medical oncologists, radiation oncologists, pathologists, and radiologists. The recommendation you receive is the consensus of specialists — not one doctor's view.
VATS and robotic keyhole surgery, targeted therapy, immunotherapy, SABR radiotherapy, proton beam therapy, neoadjuvant approaches, and access to clinical trials — all assessed for relevance to your specific case and molecular profile.
For eligible patients with NSCLC, genomic testing identifies targetable mutations that can guide systemic therapy choices. If your biopsy has not already been tested, rapid molecular profiling can often be arranged within days.
You receive a clear written summary of the second-opinion findings and recommendations. You are completely free to take this back to your NHS team or use it to inform a decision to proceed with Mr Scarci's team. There is no obligation whatsoever to change providers.
Lung cancer treatment decisions should never rest on one specialist's assessment. The multidisciplinary team meeting is the gold standard in cancer care — the forum where multiple experts challenge each other's thinking to arrive at the best possible recommendation for each individual patient.
Every second-opinion case reviewed through this service is formally presented at a comprehensive cancer MDT meeting. You receive the collective expertise of the full team — not a single clinician working alone.
Start your second opinion →Already receiving NHS care?A private second opinion does not mean leaving the NHS. You can return to your NHS team afterwards, or proceed privately — the choice is always yours.
Book a Second Opinion →Book online, call 020 7459 4367, or use WhatsApp. No referral needed.
Day 1Your scans and medical records are obtained electronically. No need to collect anything yourself.
24–48 hoursA thorough, unhurried consultation with Mr Scarci — in person at one of four London locations, or online.
Within one weekYour case is formally discussed at the multidisciplinary team meeting. The full team's view is documented.
Following consultationA clear, comprehensive second-opinion report is provided — yours to take to any provider you choose.
3–5 daysThese are illustrative cases representing the kinds of outcome a specialist second opinion can produce.
Jane's initial surgeon recommended immediate surgery for what appeared to be small-cell lung cancer. Uncertain about the recommendation, she sought a second opinion. Further diagnostic testing identified a rare autoimmune condition presenting similarly to cancer on imaging. The correct diagnosis led to targeted medical therapy — and no surgery was needed.
Tom had been recommended thoracic surgery for a suspected non-small cell lung cancer. A second opinion involved a detailed review of his CT and PET imaging. The new specialist concluded the lesion was a benign growth that warranted surveillance rather than resection. Tom's decision to seek a second opinion spared him a major operation.
After a lung cancer diagnosis, Sarah's initial plan felt disproportionately aggressive for her circumstances. A second opinion consultation with Mr Scarci provided a more personalised, less invasive plan — combining minimally invasive keyhole surgery with a targeted systemic approach aligned with her molecular profile.
A lung cancer second opinion with Mr Marco Scarci means a thorough review of your entire case — by the surgeon, by the MDT team, and with access to the full range of modern treatment options. You leave knowing whether the plan you've been given is the best one for you.
020 7459 4367
020 7459 4367